Centessa Pharmaceuticals【0ACX】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

買値

売値

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

発行済株式数

0.00

配当利回り

PER

0.00

1 株当たり利益 (EPS)

歳入

6.85M

純利益

-151.09M

セクター

Coml Physical, Biologcl Resh

業界

Coml Physical, Biologcl Resh

ウェブサイト

www.centessa.com

本社

Cheshire, Gbr

設立

Centessa Pharmaceuticals Plc is listed in the Coml Physical, Biologcl Resh sector of the ロンドン証券取引所 with ticker 0ACX. The last closing price for Centessa Pharmaceuticals was -. Over the last year, Centessa Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Centessa Pharmaceuticals currently has 0 shares in issue.

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals...

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq:...

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers 2.5 mg dose restored normative...

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep...

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024 Company advancing pipeline of potential best-in-class orexin receptor 2 (OX2R) agonists...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

銘柄コード	株価	出来高
MTCMothercare Plc	4.90p (37.64%)	2.85M
WSBNWishbone Gold Plc	0.375p (25.00%)	6.43M
PRIMPrimorus Investments Plc	4.25p (21.43%)	502.39k
HEMOHemogenyx Pharmaceuticals Plc	1.35p (21.18%)	18.73M
TRLSTrellus Health Plc	0.75p (19.05%)	436.72k
FUTRFuture Plc	834.50p (-15.19%)	1.01M
NFXNuformix Plc	0.055p (-12.00%)	820.13k
JADEJade Road Investments Limited	0.175p (-11.62%)	39.22k
AFCAfc Energy Plc	7.10p (-9.21%)	5.28M
MNRGMetalnrg Plc	0.50p (-9.09%)	67.55M
MSMNMosman Oil And Gas Limited	0.054p (9.31%)	452.77M
TRPTower Resources Plc	0.0295p (-3.28%)	227.45M
DKEDukemount Capital Plc	0.035p (4.48%)	189.92M
NTVONativo Resources Plc	0.0026p (0.00%)	150.17M
PREMPremier African Minerals Limited	0.0435p (-5.43%)	131.73M

銘柄コード

株価

出来高